Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer.

Objectives: Older patients with cancer have increased risk for comorbidity, polypharmacy (PP) and drug related problems (DRP). The aim of this study was to assess the effect of a clinical pharmacist and geriatrician medication review (MR) among older outpatients with cancer to optimize management of comorbidities during comprehensive geriatric assessment (CGA).

Material And Methods: We conducted a single-center prospective study among older outpatients with cancer (≥75 years).

Quality of life determinants in older patients with cancer: Results from a French prospective monocenter cohort.

Objectives: The aim of this study is to describe determinants of quality of life (QOL) quoted by vulnerable older patients with cancer and compare them with domains included in cancer-specific QOL questionnaires.

Material And Methods: This prospective, monocenter, observational study was performed in a French university hospital. Cancer patients Patients with cancer aged over 74 years were recruited when referred for an out-patient geriatric evaluation (n = 102).

[Cognitive decline in geriatric oncology: Trends, evaluation and treatment].

Cancer prevalence increases with aging. Prevalent or incident neurocognitive disorders are frequent in geriatric oncology. Cognitive decline associated with cancer increases the risk of under or over-cancer treatment and makes therapeutic decisions complex.